These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29916835)

  • 41. Adult extracorporeal life support: a failed or forgotten concept?
    Colafranceschi AS; Monteiro AJ; Canale LS; Campos LA; Montera MW; Silva PR; Fernandes MR; Pinto Ade A; Molas SM; Mesquita ET
    Arq Bras Cardiol; 2008 Jul; 91(1):34-41. PubMed ID: 18660943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiogenic shock: drug therapy and cardiac support systems].
    Wacker P; Werdan K
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2474-7. PubMed ID: 22109579
    [No Abstract]   [Full Text] [Related]  

  • 43. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Percutaneous circulatory support for biventricular failure.
    Nagy CD; Jumean MF; Pham DT; Kiernan MS; Denofrio D; Kapur NK
    Circ Cardiovasc Interv; 2013 Apr; 6(2):e12-4. PubMed ID: 23591421
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanical circulatory support for cardiogenic shock.
    Subramaniam K; Boisen M; Shah PR; Ramesh V; Pete A
    Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):131-46. PubMed ID: 22910086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal timing of left ventricular assist device implantation for severe heart failure patients: focus on end-organ function not hemodynamics.
    Ooka T; Matsui Y
    Circ J; 2012; 76(7):1587-8. PubMed ID: 22789976
    [No Abstract]   [Full Text] [Related]  

  • 47. Trends in the Use of Mechanical Circulatory Support Devices in Patients Presenting With ST-Segment Elevation Myocardial Infarction.
    Agarwal S; Sud K; Martin JM; Menon V
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1772-4. PubMed ID: 26585627
    [No Abstract]   [Full Text] [Related]  

  • 48. Current status of percutaneous ventricular assist devices for cardiogenic shock.
    Basra SS; Loyalka P; Kar B
    Curr Opin Cardiol; 2011 Nov; 26(6):548-54. PubMed ID: 21926617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Salvage from Extracorporeal Membrane Oxygenation due to Acute Deteriorated Heart Failure;Treatment Decision-tree Based on the Risk Factors].
    Mizuno T; Fujiwara T; Kuroki H; Oishi K; Kubo T; Oi K; Yashima M; Takeshita S; Okumura Y; Nabeshima J; Arai H
    Kyobu Geka; 2018 Jul; 71(7):526-531. PubMed ID: 30042257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrating Interventional Cardiology and Heart Failure Management for Cardiogenic Shock.
    Kapur NK; Davila CD; Jumean MF
    Interv Cardiol Clin; 2017 Jul; 6(3):481-485. PubMed ID: 28600099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ["Catecholamine refractory" cardiogenic shock? "Bridging-to-recovery" by implantation of a percutaneous cardiac assist device].
    Wilde J; Klingel K; Kandolf R; Schuler G; Sandri M
    Dtsch Med Wochenschr; 2013 Mar; 138(12):576-80. PubMed ID: 23483417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-Term Circulatory and Right Ventricle Support in Cardiogenic Shock: Extracorporeal Membrane Oxygenation, Tandem Heart, CentriMag, and Impella.
    Sultan I; Kilic A; Kilic A
    Heart Fail Clin; 2018 Oct; 14(4):579-583. PubMed ID: 30266366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective.
    Atkinson TM; Ohman EM; O'Neill WW; Rab T; Cigarroa JE;
    JACC Cardiovasc Interv; 2016 May; 9(9):871-83. PubMed ID: 27151604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding the complexity of cardiogenic shock management: the added value of advanced computational modeling.
    Meuwese CL; van Loon LM; Donker DW
    Curr Opin Crit Care; 2024 Aug; 30(4):340-343. PubMed ID: 38841981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hand-held minimised extracorporeal membrane oxygenation: a new bridge to recovery in patients with out-of-centre cardiogenic shock.
    Arlt M; Philipp A; Voelkel S; Camboni D; Rupprecht L; Graf BM; Schmid C; Hilker M
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):689-94. PubMed ID: 21349735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracorporeal membrane oxygenation in pheochromocytoma-induced cardiogenic shock.
    Bouabdallaoui N; Bouchard D; Jolicoeur EM; Chronopoulos A; Garneau PY; Lamarche Y
    Asian Cardiovasc Thorac Ann; 2018 May; 26(4):314-316. PubMed ID: 28823181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations.
    Ouweneel DM; Henriques JP
    Heart; 2012 Aug; 98(16):1246-54. PubMed ID: 22826561
    [No Abstract]   [Full Text] [Related]  

  • 58. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association.
    Kociol RD; Cooper LT; Fang JC; Moslehi JJ; Pang PS; Sabe MA; Shah RV; Sims DB; Thiene G; Vardeny O;
    Circulation; 2020 Feb; 141(6):e69-e92. PubMed ID: 31902242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pathophysiological approach to the patient in shock.
    Mouchawar A; Rosenthal M
    Int Anesthesiol Clin; 1993; 31(2):1-20. PubMed ID: 8314621
    [No Abstract]   [Full Text] [Related]  

  • 60. The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK.
    Borisenko O; Wylie G; Payne J; Bjessmo S; Smith J; Firmin R; Yonan N
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):41-8. PubMed ID: 24667583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.